Related Experiment Video
Updated: Apr 28, 2026

Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models
Published on: August 18, 2023
Effect of inhaler design variables on paediatric use of dry powder inhalers
Anne J Lexmond1, Tonnis J Kruizinga1, Paul Hagedoorn1
1Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, Groningen, The Netherlands.
Insights
Developing effective pediatric dry powder inhalers (DPIs) requires understanding airflow resistance and mouthpiece design. Medium-high resistance and specific mouthpiece shapes are suitable and preferred by children aged 5-12.
Area of Science:
- Pulmonary drug delivery
- Pediatric respiratory devices
- Inhaler technology
Background:
- Dry powder inhaler (DPI) performance is highly dependent on patient inspiratory maneuvers, posing challenges for pediatric use.
- Previous studies on pediatric DPIs often focused on specific devices or limited inspiratory parameters.
Purpose of the Study:
- To broadly investigate the requirements for a pediatric DPI using an instrumented test inhaler.
- To assess the impact of airflow resistance on children's inspiratory flow profiles.
- To evaluate children's preferences for airflow resistance and mouthpiece design in relation to suitability.
Main Methods:
- Tested 98 children (aged 4.7-12.6 years) using an instrumented test inhaler across five airflow resistances.
- Recorded and analyzed inspiratory flow profiles, calculating key inspiratory flow parameters.
- Utilized a sinuscope to identify oral cavity obstructions during inhalation.
Main Results:
- Both airflow resistance and child characteristics significantly influenced inspiratory parameters.
- Medium-high airflow resistance was found to be suitable and preferred by children aged 5-12 years.
- High incidences of oral obstructions (up to 90%) were observed, potentially limiting DPI use, though an oblong mouthpiece improved oral passageway.
Conclusions:
- A pediatric DPI should achieve a high fine particle dose within 0.5 L inhaled volume and a peak inspiratory flow rate of 25-40 L/min for children aged 5+.
- Future pediatric inhaler development should consider these findings regarding airflow resistance, mouthpiece design, and potential obstructions.
Abstract:
Age appropriateness is a major concern of pulmonary delivery devices, in particular of dry powder inhalers (DPIs), since their performance strongly depends on the inspiratory flow manoeuvre of the patient. Previous research on the use of DPIs by children focused mostly on specific DPIs or single inspiratory parameters. In this study, we investigated the requirements for a paediatric DPI more broadly using an instrumented test inhaler. Our primary aim was to assess the impact of airflow resistance on children's inspiratory flow profiles. Additionally, we investigated children's preferences for airflow resistance and mouthpiece design and how these relate to what may be most suitable for them. We tested 98 children (aged 4.7-12.6 years), of whom 91 were able to perform one or more correct inhalations through the test inhaler. We recorded flow profiles at five airflow resistances ranging from 0.025 to 0.055 kPa0.5.min.L-1 and computed various inspiratory flow parameters from these recordings. A sinuscope was used to observe any obstructions in the oral cavity during inhalation. 256 flow profiles were included for analysis. We found that both airflow resistance and the children's characteristics affect the inspiratory parameters. Our data suggest that a medium-high resistance is both suitable for and well appreciated by children aged 5-12 years. High incidences (up to 90%) of obstructions were found, which may restrict the use of DPIs by children. However, an oblong mouthpiece that was preferred the most appeared to positively affect the passageway through the oral cavity. To accommodate children from the age of 5 years onwards, a DPI should deliver a sufficiently high fine particle dose within an inhaled volume of 0.5 L and at a peak inspiratory flow rate of 25-40 L.min-1. We recommend taking these requirements into account for future paediatric inhaler development.
Related Concept Videos
Inhaled Medications
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Drug Dosing: Infants and Children
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Factors Affecting Pulmonary Ventilation
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Pharmacokinetics in Pediatric Patients: Drug Distribution

